Results 191 to 200 of about 15,518,026 (208)

Tachykinins: Substance P, Neurokinin A, and Neurokinin B

1998
openaire   +1 more source

Distribution of Neurokinin B in Rat Spinal Cord and Peripheral Tissues: Comparison With Neurokinin a and Substance P and Effects of Neonatal Capsaicin Treatment

Neuroscience, 1992
Pierre M Laduron, C Garret, P M Laduron
exaly  

miR-206 Promotes Cancer Progression by Targeting Full-Length Neurokinin-1 Receptor in Breast Cancer.

Technology in Cancer Research and Treatment, 2019
Yunli Zhou, Yu Zhou, Dong Dong
exaly  

Neurokinin B peptide levels in normal pregnancy

European Journal of Obstetrics & Gynecology and Reproductive Biology, 2002
D'ANNA, Rosario, CORRADO, Francesco, BAVIERA, Giovanni, JASONNI VM   +3 more
openaire   +3 more sources

Recent Advances in Neurokinin-3 Receptor Antagonists

Expert Opinion on Therapeutic Patents, 2000
Luca F Raveglia
exaly  

Reduction of Cisplatin-Induced Emesis by a Selective Neurokinin-1–Receptor Antagonist

New England Journal of Medicine, 1999
Richard J Gralla, Rudolph Navari, Paul J Hesketh   +2 more
exaly  

A Multicenter, Double-Blind, Randomized, Placebo Controlled Trial of a Neurokinin-1 Receptor Antagonist for Overactive Bladder

Journal of Urology, 2010
Elizabeth Rosenberg
exaly  

Tachykinins (Substance P, Neurokinin a, Neuropeptide K, and Neurokinin B) in the Cerebral Circulation: Vasomotor Responses in Vitro and in Situ

Journal of Cerebral Blood Flow and Metabolism, 1991
Lars Edvinsson, R Uddman, Inger Jansen
exaly  

Randomized, Double-Blind, Dose-Ranging Trial of the Oral Neurokinin-1 Receptor Antagonist Casopitant Mesylate for the Prevention of Cisplatin-Induced Nausea and Vomiting

Annals of Oncology, 2009
Fausto Roila, R Ramlau
exaly  

Neurokinin Receptor Antagonists

Expert Opinion on Therapeutic Patents, 1999
Christopher J Swain
exaly